FDA Serves Up More Warnings: Avon Cited For Touting Druglike Benefits

Claims cited in FDA’s warning to Avon Products Inc. include statements suggesting collagen-building and wrinkle-plumping benefits, as well as comparisons to in-clinic injections and the assertion that technology in the firm’s Anew Reversalist products can help “reactivate skin’s repair process to recreate fresh skin.” Avon has 15 days to reply.